Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...

Marianne De Backer took over as CEO of Vir in 2023. Since then she has shuttered three sites and laid off more than a third ...

PDS Biotechnology (NASDAQ:PDSB) reported a smaller first-quarter loss and highlighted changes to its late-stage head and neck ...

(Michael on for Roanna Ruiz), Leerink Partners: "what would constitute a clear signal as a green light to initiate Phase III in 2027?"; President, CEO & Director De Backer: "it's going to really be ...

Puma Biotechnology, Inc. (NASDAQ:PBYI) just released its latest quarterly results and things are looking bullish. Revenues and losses per share were both better than expected, wit ...

U.S. Food and Drug Administration Commissioner Dr. Marty Makary's departure comes as a positive move after a period of ...

Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...

Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on VIR. Vir Biotechnology, ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

View PDS Biotechnology Corp. PDSB stock quote prices, financial information, real-time forecasts, and company news from CNN.